$2.35B
$4.55 Million
0.0% of portfolio
253,971
Q2 2024
Added 69.32%
-
$0
0.0% of portfolio
-
Q4 2023
New
$1.02B
$2.21 Million
0.0% of portfolio
215,269
Q2 2024
Added 96.99%
Accelerate Diagnostics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 8.18%
$489M
$3.22 Million
0.0% of portfolio
685,011
Q2 2024
Added 31.17%
$252M
$904,000
0.0% of portfolio
252,543
Q2 2024
Reduced 32.77%
$177M
$185,000
0.0% of portfolio
101,732
Q2 2024
Added 84.48%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 41.08%
Achieve Life Sciences Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 17.83%
$5.78B
$23.3 Million
0.0% of portfolio
588,757
Q2 2024
Added 707.51%
-
$0
0.0% of portfolio
-
Q2 2024
Added 67.0%
$79.3M
$7,000
0.0% of portfolio
6,495
Q2 2024
Reduced 74.68%
$1.04B
$5.26 Million
0.0% of portfolio
228,082
Q2 2024
Reduced 71.87%
$143M
$4,000
0.0% of portfolio
126
Q2 2024
Reduced 95.54%
$376M
$329,000
0.0% of portfolio
9,072
Q2 2024
Added 17.5%
Acres Commercial Realty Corp
-
$0
0.0% of portfolio
-
Q2 2024
Added 128.71%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 66.23%
-
$0
0.0% of portfolio
-
Q2 2024
Added 356.2%
-
$0
0.0% of portfolio
-
Q2 2024
New
$45.8M
$307,000
0.0% of portfolio
41,571
Q2 2024
Added 6.42%
$116M
$296,000
0.0% of portfolio
122,725
Q2 2024
Added 52.23%
$23.2M
$0
0.0% of portfolio
105
Q2 2024
New
$4.43B
$9.38 Million
0.0% of portfolio
147,714
Q2 2024
Reduced 2.07%
$2.19B
$16.2 Million
0.0% of portfolio
889,318
Q2 2024
Added 9.6%
$587M
$3.71 Million
0.0% of portfolio
156,979
Q2 2024
Reduced 37.48%
-
$0
0.0% of portfolio
-
Q2 2024
New
$2.58B
$8.19 Million
0.0% of portfolio
380,969
Q2 2024
Reduced 8.57%
$115M
$0
0.0% of portfolio
20
Q2 2024
New
$1.48B
$1.94 Million
0.0% of portfolio
194,083
Q2 2024
Added 10.26%
$137M
$4.56 Million
0.0% of portfolio
4,653,325
Q2 2024
Reduced 0.31%
$669M
$4.13 Million
0.0% of portfolio
1,141,204
Q2 2024
Added 120.62%
$242M
$3.84 Million
0.0% of portfolio
1,216,418
Q2 2024
Added 1.89%
$2.12B
$10.5 Million
0.0% of portfolio
90,580
Q2 2024
Added 185.27%
$1.26B
$3.07 Million
0.0% of portfolio
315,268
Q2 2024
Reduced 20.46%
$1.3B
$3.3 Million
0.0% of portfolio
295,322
Q2 2024
Added 40.51%
Adial Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$58M
$85,000
0.0% of portfolio
70,438
Q2 2024
Reduced 30.94%
$2.16B
$6.89 Million
0.0% of portfolio
278,711
Q2 2024
Added 5.38%
-
$0
0.0% of portfolio
-
Q2 2024
New
$3.1B
$9.96 Million
0.0% of portfolio
890,662
Q2 2024
Added 65.11%
$6.09B
$12.6 Million
0.0% of portfolio
1,652,936
Q2 2024
Added 23.67%
$3.31B
$10.6 Million
0.0% of portfolio
155,434
Q2 2024
Reduced 10.9%
$489M
$3.26 Million
0.0% of portfolio
619,974
Q2 2024
Reduced 10.19%
$2.39B
$38.9 Million
0.0% of portfolio
614,239
Q2 2024
Added 22.99%
$843M
$915,000
0.0% of portfolio
39,931
Q2 2024
Added 31.88%
$1B
$505,000
0.0% of portfolio
156,907
Q2 2024
Added 161.17%
$0
$626,000
0.0% of portfolio
52,590
Q2 2024
Reduced 45.03%
Advent Technologies Holdng I
-
$0
0.0% of portfolio
-
Q2 2024
New
Adverum Biotechnologies Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 6.41%
-
$0
0.0% of portfolio
-
Q1 2024
New